Publication | Closed Access

Infarct Size Limitation by a New Na-H Exchange Inhibitor, Hoe 642: Difference From Preconditioning in the Role of Protein Kinase C

Hoe 642Protein Kinase CCardiovascular DiseaseCell SignalingMedicineImmunologyVascular BiologyPharmacotherapyReperfusion InjuryPharmacologyAtherosclerosisIschemic SyndromeInfarct Size Limitation